or Try an Advanced Search...

    Technical Analysis for ITRM - Iterum Therapeutics plc

    Grade Last Price % Change Price Change
    B 1.70 3.99% 0.07
    ITRM closed up 7.24 percent on Wednesday, November 20, 2024, on 35 percent of normal volume.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Up
    Historical ITRM trend table...
    Date Alert Name Type % Chg
    Wide Bands Range Expansion 3.99%
    Up 3 Days in a Row Strength 3.99%
    Up 4 Days in a Row Strength 3.99%
    Wide Bands Range Expansion 11.51%
    Up 3 Days in a Row Strength 11.51%
    20 DMA Support Bullish 19.37%
    200 DMA Support Bullish 19.37%
    Spinning Top Other 19.37%
    Wide Bands Range Expansion 19.37%
    20 DMA Support Bullish 23.72%
    Older End-of-Day Signals for ITRM ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Previous Day's High about 1 hour ago
    Down 3% about 1 hour ago
    Up 5% about 1 hour ago
    Up 3% about 1 hour ago
    Down 2 % about 1 hour ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    ITRM Chart by TradingView
    Basic chart:

    Profile

    Iterum Therapeutics PLC is a clinical-stage pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Pharmaceutical Stage Pharmaceutical

    Is ITRM a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 21 Iterum Therapeutics regains full Nasdaq compliance
    Nov 21 Iterum Therapeutics Regains Full Nasdaq Compliance
    Nov 15 Iterum Therapeutics PLC (ITRM) Q3 2024 Earnings Call Highlights: Strategic Moves Amid Financial ...
    Nov 14 Iterum Therapeutics plc (ITRM) Q3 2024 Earnings Call Transcript
    Nov 14 Earnings Scheduled For November 14, 2024
    Nov 11 Iterum Therapeutics to Report Third Quarter 2024 Financial Results on November 14, 2024
    Oct 28 Iterum Therapeutics plc (ITRM) U.S. FDA Approval of ORLYNVAH Call (Transcript)
    Oct 28 FDA Approval Of Orlynvah For Urinary Tract Infections Marks Milestone For Iterum, Paves Way For New Strategic Partnerships
    Oct 28 FDA approves Iterum’s ORLYNVAH NDA for uUTI treatment
    Oct 28 Iterum Therapeutics to Host Morning Conference Call on U.S. FDA Approval of ORLYNVAH™ (Oral Sulopenem) for the Treatment of Uncomplicated Urinary Tract Infections
    See more ITRM news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 2.5
    52 Week Low 0.808
    Average Volume 2,998,306
    200-Day Moving Average 1.33
    50-Day Moving Average 1.19
    20-Day Moving Average 1.39
    10-Day Moving Average 1.43
    Average True Range 0.16
    RSI (14) 63.90
    ADX 38.91
    +DI 36.80
    -DI 13.32
    Chandelier Exit (Long, 3 ATRs) 1.84
    Chandelier Exit (Short, 3 ATRs) 1.53
    Upper Bollinger Bands 1.71
    Lower Bollinger Band 1.07
    Percent B (%b) 0.88
    BandWidth 45.69
    MACD Line 0.09
    MACD Signal Line 0.08
    MACD Histogram 0.016
    Fundamentals Value
    Market Cap 21.9 Million
    Num Shares 13.4 Million
    EPS -2.43
    Price-to-Earnings (P/E) Ratio -0.67
    Price-to-Sales 1349.79
    Price-to-Book 6.30
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.83
    Resistance 3 (R3) 1.82 1.73 1.80
    Resistance 2 (R2) 1.73 1.68 1.74 1.79
    Resistance 1 (R1) 1.68 1.65 1.71 1.70 1.78
    Pivot Point 1.60 1.60 1.61 1.61 1.60
    Support 1 (S1) 1.55 1.55 1.57 1.56 1.48
    Support 2 (S2) 1.46 1.51 1.47 1.47
    Support 3 (S3) 1.41 1.46 1.46
    Support 4 (S4) 1.43